author-photo

Kenneth K. Ng

Memorial Sloan Kettering Cancer Center

31

Papers

775

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center.

2021 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
COVID-19 in patients with lung cancer.

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (79)
A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers

2018 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (84)
A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed PD-L1 IHC low/unknown stage IV squamous cell lung cancers.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
P2.02-060 SBRT and Sequential Chemotherapy for Stage IIA to IIIA Non-Small Cell Lung Cancer - A Phase I Dose Escalation Study: Topic: RT Techniques

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC)

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (21)
Phase I/II Trial of Weekly Intravenous 130-nm Albumin-Bound Paclitaxel As Initial Chemotherapy in Patients With Stage IV Non–Small-Cell Lung Cancer

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (104)
A phase II study to determine if sensory neuropathy of nab-paclitaxel can be reduced by prolonging infusion in patients with non-small cell lung cancer (NSCLC)

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)